SCHEMBL5773495

SCHEMBL5773495

Cc1nc(Cl)c([N+](=O)[O-])c(N2CCCCC2)n1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2D6 P10635 1/20 0.52
ALDH1A1 P00352 4/20 0.51
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPT P10636 2/20 0.43
MAPK1 P28482 2/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CHRM3 P20309 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9122461 0.87 MAPT (0.47) HTTCYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL9126475 0.85 ALDH1A1 (0.56) HTTCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL6947517 0.83 MEN1 (0.44) HTTCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL11306741 0.79 ALDH1A1 (0.61) HTTCYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL17376514 0.76 FFAR2 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL17376374 0.76 FFAR2 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL17376417 0.76 FFAR2 (0.42) CYP1A2CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL1123974 0.76 MAPT (0.39) ALDH1A1NPC1RAB9AMAPTPOLB
SCHEMBL7958841 0.75 NPY5R (0.39) HTTCYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL693908 0.75 ALDH1A1 (0.48) HTTCYP1A2CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed